Endologix Inc
ELGX
ELGX was delisted on the 15th of July, 2020.
57 hedge funds and large institutions have $20.6M invested in Endologix Inc in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 10 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 63 → 57 (-6)
20% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 20
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
62% less capital invested
Capital invested by funds: $54.4M → $20.6M (-$33.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$349K |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$264K |
| 3 |
D.E. Shaw & Co
New York
|
+$187K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$134K |
| 5 |
Renaissance Technologies
New York
|
+$124K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
-$2.38M |
| 2 |
Morgan Stanley
New York
|
-$589K |
| 3 |
Axa
Paris,
France
|
-$371K |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$308K |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$265K |
ELGX Hedge Fund Activity: Q4 2019 in Review
57 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Endologix Inc (ELGX) for Q4 2019, worth a combined $20.6M — down 62% from $54.4M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ELGX and 4 opened new positions — a net loss of 6 holders — while 20 trimmed existing stakes and 16 added.
The largest buyer was Jacobs Levy Equity Management, adding an estimated $349K. The largest seller was Palisade Capital Management, exiting entirely with an estimated $2.38M sold.
- 57 institutional investors held Endologix Inc (ELGX) as of Q4 2019, down from 63 in Q3 2019.
- Funds reported $20.6M of Endologix Inc stock for Q4 2019, down 62% quarter-over-quarter.
- 4 funds opened new Endologix Inc positions in Q4 2019 and 10 closed out, a net change of -6 holders.
- The largest Endologix Inc buyer in Q4 2019 was Jacobs Levy Equity Management, an estimated $349K added.
- The largest Endologix Inc seller in Q4 2019 was Palisade Capital Management, an estimated $2.38M sold.
Based on aggregated 13F filings for Q4 2019.